Literature DB >> 17866194

PAROXYSMAL HYPERTENSION ASSOCIATED WITH TUMOR OF THE SUPRARENAL.

A M Shipley.   

Abstract

Entities:  

Year:  1929        PMID: 17866194      PMCID: PMC1399085          DOI: 10.1097/00000658-192910000-00028

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  11 in total

1.  The Ocular Fundus in Pheochromocytoma of the Adrenal Gland. Report of 3 Cases.

Authors:  G M Bruce
Journal:  Trans Am Ophthalmol Soc       Date:  1947

2.  EPINEPHRINE HYPERTENSION: THE EFFECT OF THE CONTINUOUS INTRAVENOUS INJECTION OF EPINEPHRINE ON THE BLOOD PRESSURE AN EXPERIMENTAL INVESTIGATION.

Authors:  J Van Prohaska; H P Harms; L R Dragstedt
Journal:  Ann Surg       Date:  1937-11       Impact factor: 12.969

3.  THE SUPRARENAL CORTICAL SYNDROME WITH PRESENTATION OF TEN CASES.

Authors:  W Walters; R M Wilder; E J Kepler
Journal:  Ann Surg       Date:  1934-10       Impact factor: 12.969

4.  Subtotal Bilateral Adrenalectomy for Hyperadrenalism (Essential Hypertension).

Authors:  J L Decourcy
Journal:  Ann Surg       Date:  1934-08       Impact factor: 12.969

5.  Experimental Hypertension Induced by Renal Ischemia: Harvey Lecture, May 19, 1938.

Authors:  H Goldblatt
Journal:  Bull N Y Acad Med       Date:  1938-09

6.  Surgical Lesions of the Adrenal Glands.

Authors:  W Walters
Journal:  Cal West Med       Date:  1941-08

7.  A case of adrenal phaeochromocytoma.

Authors:  J F PANTRIDGE; M M BURROWS
Journal:  Br Med J       Date:  1951-03-03

8.  Medullary suprarenal chromaffinoma producing malignant hypertension.

Authors:  D GUTMANN
Journal:  Br Med J       Date:  1947-04-26

9.  Essential and paroxysmal hypertension, contrasted by case reports.

Authors:  F H Foucar
Journal:  Am J Pathol       Date:  1939-11       Impact factor: 4.307

10.  The surgical management of chromaffin tumors.

Authors:  F Glenn; H Mannix
Journal:  Ann Surg       Date:  1968-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.